Operating Expenses Summary of Raia Drogasil S.A.

Raia Drogasil S.A.'s latest annual operating expenses in 2023 was 8.12 Billion BRL , up 18.47% from previous year.
Raia Drogasil S.A.'s latest quarterly operating expenses in 2024 Q2 was 1.83 Billion BRL , up 7.85% from previous quarter.
Raia Drogasil S.A. reported a annual operating expenses of 6.97 Billion BRL in annual operating expenses 2022, up 19.61% from previous year.
Raia Drogasil S.A. reported a annual operating expenses of 5.83 Billion BRL in annual operating expenses 2021, up 17.49% from previous year.
Raia Drogasil S.A. reported a quarterly operating expenses of 1.83 Billion BRL for 2024 Q2, up 7.85% from previous quarter.
Raia Drogasil S.A. reported a quarterly operating expenses of 2.27 Billion BRL for 2023 Q4, up 7.85% from previous quarter.

Annual Operating Expenses Chart of Raia Drogasil S.A. (2023 - 2003)

Historical Annual Operating Expenses of Raia Drogasil S.A. (2023 - 2003)

Year	Operating Expenses	Operating Expenses Growth
2023	8.12 Billion BRL	18.47%
2022	6.97 Billion BRL	19.61%
2021	5.83 Billion BRL	17.49%
2020	4.96 Billion BRL	15.34%
2019	4.3 Billion BRL	16.99%
2018	3.67 Billion BRL	15.11%
2017	3.19 Billion BRL	14.18%
2016	2.79 Billion BRL	26.42%
2015	2.21 Billion BRL	22.91%
2014	1.8 Billion BRL	14.69%
2013	1.57 Billion BRL	17.89%
2012	1.33 Billion BRL	108.66%
2011	638.36 Million BRL	74.34%
2010	366.16 Million BRL	21.23%
2009	302.04 Million BRL	14.81%
2008	263.08 Million BRL	29.29%
2007	203.48 Million BRL	-3.74%
2006	211.39 Million BRL	54.83%
2005	136.52 Million BRL	21.46%
2004	112.4 Million BRL	14.1%
2003	98.51 Million BRL	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q1	1.69 Billion BRL	-25.29%
2024 Q2	1.83 Billion BRL	7.85%
2023 Q4	2.27 Billion BRL	7.85%
2023 Q3	2.1 Billion BRL	5.87%
2023 Q1	1.89 Billion BRL	0.03%
2023 Q2	1.99 Billion BRL	5.29%
2023 FY	8.26 Billion BRL	18.47%
2022 Q4	1.88 Billion BRL	7.24%
2022 Q1	1.66 Billion BRL	1.44%
2022 Q2	1.67 Billion BRL	0.31%
2022 FY	6.97 Billion BRL	19.61%
2022 Q3	1.76 Billion BRL	5.39%
2021 Q3	1.49 Billion BRL	10.13%
2021 FY	5.83 Billion BRL	17.49%
2021 Q4	1.64 Billion BRL	9.97%
2021 Q1	1.33 Billion BRL	0.68%
2021 Q2	1.35 Billion BRL	1.32%
2020 Q1	1.18 Billion BRL	-15.14%
2020 Q2	1.19 Billion BRL	0.95%
2020 Q4	1.33 Billion BRL	9.77%
2020 FY	4.96 Billion BRL	15.34%
2020 Q3	1.21 Billion BRL	0.99%
2019 Q3	1.1 Billion BRL	6.04%
2019 FY	4.3 Billion BRL	16.99%
2019 Q1	1 Billion BRL	0.37%
2019 Q2	1.04 Billion BRL	3.85%
2019 Q4	1.4 Billion BRL	26.31%
2018 Q1	850.61 Million BRL	0.39%
2018 FY	3.67 Billion BRL	15.11%
2018 Q4	1 Billion BRL	7.8%
2018 Q3	930.54 Million BRL	4.08%
2018 Q2	894.05 Million BRL	5.11%
2017 Q1	757.28 Million BRL	-1.45%
2017 Q4	847.29 Million BRL	4.51%
2017 FY	3.19 Billion BRL	14.18%
2017 Q3	810.69 Million BRL	3.92%
2017 Q2	780.14 Million BRL	3.02%
2016 Q4	768.41 Million BRL	7.24%
2016 FY	2.79 Billion BRL	26.42%
2016 Q1	627.03 Million BRL	0.86%
2016 Q3	716.52 Million BRL	4.36%
2016 Q2	686.62 Million BRL	9.5%
2015 FY	2.21 Billion BRL	22.91%
2015 Q2	534.32 Million BRL	8.69%
2015 Q4	621.66 Million BRL	9.82%
2015 Q3	566.09 Million BRL	5.95%
2015 Q1	491.62 Million BRL	1.26%
2014 FY	1.8 Billion BRL	14.69%
2014 Q1	419.78 Million BRL	-1.16%
2014 Q2	436.49 Million BRL	3.98%
2014 Q3	459.3 Million BRL	5.23%
2014 Q4	485.48 Million BRL	5.7%
2013 Q4	424.72 Million BRL	0.56%
2013 FY	1.57 Billion BRL	17.89%
2013 Q3	422.37 Million BRL	15.18%
2013 Q2	366.7 Million BRL	2.85%
2013 Q1	356.54 Million BRL	-5.23%
2012 Q1	301.35 Million BRL	-2.59%
2012 FY	1.33 Billion BRL	108.66%
2012 Q4	376.2 Million BRL	12.4%
2012 Q3	334.69 Million BRL	4.66%
2012 Q2	319.77 Million BRL	6.11%
2011 FY	638.36 Million BRL	74.34%
2011 Q3	115.24 Million BRL	6.83%
2011 Q2	107.88 Million BRL	1.9%
2011 Q1	105.86 Million BRL	4.49%
2011 Q4	309.37 Million BRL	168.45%
2010 Q1	113.35 Million BRL	38.57%
2010 FY	366.16 Million BRL	21.23%
2010 Q4	101.31 Million BRL	7.17%
2010 Q3	94.53 Million BRL	-2.26%
2010 Q2	96.71 Million BRL	-14.68%
2009 FY	302.04 Million BRL	14.81%
2009 Q4	81.8 Million BRL	6.06%
2009 Q3	77.12 Million BRL	-5.01%
2009 Q2	81.19 Million BRL	-9.63%
2009 Q1	89.85 Million BRL	0.0%
2008 FY	263.08 Million BRL	29.29%
2007 FY	203.48 Million BRL	-3.74%
2006 FY	211.39 Million BRL	54.83%
2005 FY	136.52 Million BRL	21.46%
2004 FY	112.4 Million BRL	14.1%
2003 FY	98.51 Million BRL	0.0%

Peer Operating Expenses Comparison of Raia Drogasil S.A.

Name	Operating Expenses	Operating Expenses Difference
Alternative Energy Partners, Inc.	3437.19 USD	-236439404.363%
Allstar Health Brands, Inc.	215.74 Thousand USD	-3766754.232%
Beijing Tong Ren Tang Chinese Medicine Company Limited	55.24 Million USD	-14611.474%
Café Serendipity Holdings, Inc.	1.43 Million USD	-565724.102%
Decision Diagnostics Corp.	- USD	-Infinity%
Health Advance Inc.	47.57 Thousand USD	-17083934.055%
HealthWarehouse.com, Inc.	13.79 Million USD	-58809.194%
LIGAND PHARMACEUTICAL INC	78.2 Million USD	-10291.759%
MedGen, Inc.	16.59 USD	-48986588206.209%
Omni Health, Inc.	1.14 Million USD	-708417.069%
Oxford Investments Holdings Inc.	373.76 Thousand USD	-2174250.721%
Pineapple, Inc.	452.94 Thousand USD	-1794118.1%
ScripsAmerica, Inc.	31.4 Million USD	-25778.147%

Global Stocks Search

Raia Drogasil S.A. (RADLY)

Operating Expenses Summary of Raia Drogasil S.A.

Annual Operating Expenses Chart of Raia Drogasil S.A. (2023 - 2003)

Historical Annual Operating Expenses of Raia Drogasil S.A. (2023 - 2003)

Peer Operating Expenses Comparison of Raia Drogasil S.A.